Santa Cruz Biotechnology offers a broad range of HLA-D monoclonal antibodies for advanced research in immunology and cell biology. HLA-D monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HLA-D proteins are fundamental components in immune response mechanisms, presenting peptides to CD4+ T cells and influencing immune response activation and regulation. Understanding HLA-D function is critical for research in autoimmune diseases, transplant rejection, and infectious diseases. Researchers worldwide rely on HLA-D monoclonal antibodies to advance their understanding of immune system dynamics. Each HLA-D monoclonal antibody undergoes quality control to ensure consistent and reproducible results. Advanced research techniques benefit from the high specificity and sensitivity of HLA-D monoclonal antibodies in detecting target proteins. Santa Cruz Biotechnology's HLA-D monoclonal antibodies enable scientists to make meaningful contributions to immunology research and therapeutic development.